ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
효소면역측정법 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.2%로 283억 7,000만 달러에 달할 전망입니다. 예측 기간의 성장은 정부 및 NGO 주도의 질병 관리 이니셔티브, 자가면역질환 검출의 출현, 현장진단(Point-of-Care) 검사 도입 확대, 암 영역의 동반진단제 수요 증가, 고령자 증가 등에 기인하는 것으로 보입니다. 이 기간 동안 예상되는 주요 동향으로는 마이크로플레이트 리더기 및 시약의 기술 발전, 혁신적인 진단 기술 도입, 친환경 시약 개발, 면역 측정 프로세스에 AI 및 자동화 통합, 전략적 제휴 및 파트너십 증가 등을 들 수 있습니다.
감염성 질환 증가는 효소면역측정법 시장의 성장을 가속할 것으로 예측됩니다. 감염성 질환은 세균, 바이러스, 곰팡이, 기생충 등 유해한 미생물에 의해 발생하는 질병으로 개인 간 감염이 가능합니다. 항균제 내성균 증가로 인해 이러한 질병의 부담이 증가하고 있으며, 치료의 복잡성, 회복 기간의 연장, 의료 비용 증가, 사망률 증가로 이어지고 있습니다. 효소면역측정법은 감염성 질환 진단에 필수적인 도구로, 환자 시료 내 항원 및 항체를 민감하고 특이적으로 검출할 수 있습니다. 이를 통해 HIV, 간염, 독감 등 질병의 조기 진단, 효과적인 모니터링, 적시 치료를 용이하게 할 수 있습니다. 예를 들어, 2025년 4월 미국 미네소타주 보건국은 35-39세 남성의 HIV 감염자 비율이 2023년 10%에서 2024년 17%로 증가했다고 보고했습니다. 그 결과, 감염성 질환의 부담 증가가 효소면역측정법 시장 확대에 기여하고 있습니다.
효소면역측정법 시장의 주요 기업들은 진단 정확도 향상, 인적 오류 감소, 임상 실험실의 워크플로우 효율화를 위해 전자동 효소면역측정법 등 첨단 솔루션 개발에 주력하고 있습니다. 전자동 효소면역측정법은 전체 검사 프로세스를 간소화하고 실험실 진단의 속도, 정확성, 신뢰성을 향상시켰습니다. 예를 들어, 일본의 체외진단용 의약품 기업 후지레비오 홀딩스는 2024년 7월 연구용(RUO) 전용 전자동 Lumipulse G GFAP Assay를 출시하여 신경 바이오마커 제품군을 확대했습니다. 이 화학발광효소면역측정법은 루미펄스G 플랫폼을 이용하여 인간 혈장 및 혈청 내 신경교섬유산성단백질(GFAP) 수치를 측정하고, 35분 이내에 결과를 확인할 수 있습니다. GFAP는 다발성 경화증, 알츠하이머병, 파킨슨병, 뇌졸중, 외상성 뇌손상 등 신경질환과 관련된 아스트로세포계 바이오마커입니다. 이 새로운 분석법은 이미 NfL, pTau217, sTREM2 등의 마커를 포함하는 후지레비오의 신경퇴행성 질환 포트폴리오를 보완하는 것으로, 단일 자동화 플랫폼에서 종합적인 프로파일링을 지원합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계 성장 분석과 전략 분석 프레임워크
세계의 효소면역측정법 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 효소면역측정법 시장 : 성장률 분석
세계의 효소면역측정법시장 실적 : 규모와 성장, 2019-2024년
세계의 효소면역측정법시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 효소면역측정법 : 전체 시장(TAM)
제6장 시장 세분화
세계의 효소면역측정법 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
시약 및 키트
분석 장비 또는 기기
소프트웨어 및 서비스
세계의 효소면역측정법 시장 : 샘플별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
혈액
타액
소변
기타 샘플
세계의 효소면역측정법 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
치료 모니터링
종양학
심장병학
내분비학
감염증 검사
자가면역질환
기타
세계의 효소면역측정법 시장 : 최종 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원
혈액은행
임상 실험실
제약 및 바이오테크놀러지 기업
학술 연구센터
기타
세계의 효소면역측정법 시장 : 시약 및 키트별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
항체
항원
기질
완충제 및 안정제
세계의 효소면역측정법 시장 : 분석 장비 또는 기기별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
전자동 EIA 분석 장비
반자동 EIA 시스템
마이크로플레이트 리더
워셔 및 인큐베이터
세계의 효소면역측정법 시장 : 소프트웨어 및 서비스별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
데이터 분석 및 해석 소프트웨어
실허밀 정보 시스템 통합 툴
기기 교정 및 검증 서비스
기술 지원 및 사용자 트레이닝
제7장 지역별/국가별 분석
세계의 효소면역측정법 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 효소면역측정법 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
효소면역측정법 시장 : 경쟁 구도
효소면역측정법 시장 : 기업 개요
F. Hoffmann-La Roche AG
Thermo Fisher Scientific Inc.
Abbott Laboratories Inc.
Danaher Corporation
Merck KGaA
제31장 기타 주요 기업 및 혁신 기업
Siemens Healthineers AG
Becton Dickinson and Company(BD)
PerkinElmer Inc.
BioMerieux SA
Bio-Rad Laboratories Inc.
Diasorin S.p.A.
Bio-Techne Corporation
Quidel Corporation
Promega Corporation
Abcam plc
BioLegend Inc.
Helena Laboratories Corporation
Cayman Chemical Company
Enzo Life Sciences Inc.
RayBIoTech Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 전략
효소면역측정법시장, 2029년 : 새로운 기회를 제공하는 국가
효소면역측정법시장, 2029년 : 새로운 기회를 제공하는 부문
효소면역측정법시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Enzyme immunoassay is a highly sensitive laboratory technique that utilizes antibodies conjugated with enzymes to specifically identify and quantify target molecules such as proteins, hormones, or infectious agents within a sample. The method is based on an enzymatic reaction that generates a detectable signal-often a color change-which correlates directly with the concentration of the analyte, enabling accurate diagnostic or research analysis.
The primary product types in enzyme immunoassay include reagents and kits, analyzers or instruments, and software and services. Reagents and kits consist of chemical substances or pre-packaged sets of chemicals used in laboratory and clinical testing to detect, measure, or process other substances. These products accommodate various specimen types, such as blood, saliva, urine, and others, and support a wide array of applications, including therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease detection, autoimmune disease testing, and more. They serve a broad range of end users, including hospitals, blood banks, clinical laboratories, pharmaceutical and biotechnology companies, academic research centers, and other institutions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The enzyme immunoassay market research report is one of a series of new reports from The Business Research Company that provides enzyme immunoassay market statistics, including enzyme immunoassay industry global market size, regional shares, competitors with an enzyme immunoassay market share, detailed enzyme immunoassay market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme immunoassay industry. This enzyme immunoassay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The enzyme immunoassay market size has grown strongly in recent years. It will grow from $20.01 billion in 2024 to $21.50 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to the increasing prevalence of infectious diseases, the expansion of blood screening programs, advancements in laboratory infrastructure, the growing application of enzyme immunoassays in food safety testing, and the rising demand for veterinary diagnostics.
The enzyme immunoassay market size is expected to see strong growth in the next few years. It will grow to $28.37 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to government and NGO-driven disease control initiatives, the emergence of autoimmune disease detection, increased adoption of point-of-care testing, rising demand for companion diagnostics in oncology, and a growing geriatric population. Key trends anticipated during this period include technological advancements in microplate readers and reagents, the introduction of innovative diagnostic technologies, development of environmentally friendly reagents, integration of AI and automation into immunoassay processes, and an increase in strategic collaborations and partnerships.
The increasing prevalence of infectious diseases is anticipated to drive the growth of the enzyme immunoassay market. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can be transmitted between individuals. The burden of these diseases is growing due to rising antimicrobial resistance, which complicates treatment, extends recovery times, raises healthcare costs, and leads to increased mortality. Enzyme immunoassays are essential tools for diagnosing infectious diseases, offering sensitive and specific detection of antigens or antibodies in patient samples. This facilitates early diagnosis, effective monitoring, and timely treatment for conditions such as HIV, hepatitis, and influenza. For example, in April 2025, the Minnesota Department of Health, a US-based government agency, reported that the proportion of HIV cases among males aged 35 to 39 increased from 10% in 2023 to 17% in 2024, reflecting a significant rise in this demographic. As a result, the increasing burden of infectious diseases is contributing to the expansion of the enzyme immunoassay market.
Leading companies in the enzyme immunoassay market are prioritizing the development of advanced solutions, such as fully automated enzyme immunoassays, to boost diagnostic accuracy, reduce human error, and improve workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays streamline the entire testing process, enhancing the speed, precision, and reliability of laboratory diagnostics. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics company, introduced the fully automated Lumipulse G GFAP assay for research use only (RUO), expanding its neuro-biomarker product line. This chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) levels in human plasma and serum using the LUMIPULSE G platform, delivering results within 35 minutes. GFAP is an astrocytic biomarker associated with neurological conditions such as multiple sclerosis, Alzheimer's and Parkinson's diseases, stroke, and traumatic brain injury. This new assay complements Fujirebio's neurodegenerative disease portfolio, which already includes markers like NfL, pTau217, and sTREM2, supporting comprehensive profiling on a single automated platform.
In January 2025, Medix Biochemica, a Finland-based supplier of raw materials for in vitro diagnostics, acquired CANDOR Bioscience GmbH for an undisclosed sum. This acquisition is aimed at strengthening Medix Biochemica's position as a leading global provider in the IVD industry by expanding its portfolio with CANDOR's specialized expertise in high-performance blockers and assay optimization reagents. These technologies support improved performance in enzyme immunoassays and enable more robust diagnostic test development. CANDOR Bioscience GmbH is a Germany-based biotechnology company that focuses on optimizing immunoassay systems, including enzyme immunoassays and ELISA development.
Major players in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMerieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, and Calbiotech Inc.
North America was the largest region in the enzyme immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in enzyme immunoassay report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the enzyme immunoassay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The enzyme immunoassay market consists of sales of enzyme-labeled antibodies, sample diluents, blocking reagents, microplate readers, ELISA test kits, robotic liquid handling systems, and plate washers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Enzyme Immunoassay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on enzyme immunoassay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for enzyme immunoassay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The enzyme immunoassay market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Reagents And Kits; Analyzers Or Instruments; Software And Services
2) By Specimen: Blood; Saliva; Urine; Other Specimens
3) By Application: Therapeutic Drug Monitoring; Oncology; Cardiology; Endocrinology; Infectious Disease Testing; Autoimmune Diseases; Other Applications
4) By End-Use: Hospitals; Blood Banks; Clinical Laboratories; Pharmaceutical And Biotech Companies; Academic Research Centers; Other End-Uses
Subsegments:
1) By Reagents And Kits: Antibodies; Antigens; Substrates; Buffers And Stabilizers
2) By Analyzers Or Instruments: Fully Automated EIA Analyzers; Semi-Automated EIA Systems; Microplate Readers; Washers And Incubators
3) By Software And Services: Data Analysis And Interpretation Software; Laboratory Information System Integration Tools; Instrument Calibration And Validation Services; Technical Support And User Training
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers AG; Becton Dickinson and Company (BD); PerkinElmer Inc.; BioMerieux SA; Bio-Rad Laboratories Inc.; Diasorin S.p.A.; Bio-Techne Corporation; Quidel Corporation; Promega Corporation; Abcam plc; BioLegend Inc.; Helena Laboratories Corporation; Cayman Chemical Company; Enzo Life Sciences Inc.; RayBiotech Inc.; MyBioSource Inc.; Boster Biological Technology; Hycult Biotech; Calbiotech Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Enzyme Immunoassay Market Characteristics
3. Enzyme Immunoassay Market Trends And Strategies
4. Enzyme Immunoassay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Enzyme Immunoassay Growth Analysis And Strategic Analysis Framework
5.1. Global Enzyme Immunoassay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Enzyme Immunoassay Market Growth Rate Analysis
5.4. Global Enzyme Immunoassay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Enzyme Immunoassay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Enzyme Immunoassay Total Addressable Market (TAM)
6. Enzyme Immunoassay Market Segmentation
6.1. Global Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reagents And Kits
Analyzers Or Instruments
Software And Services
6.2. Global Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood
Saliva
Urine
Other Specimens
6.3. Global Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease Testing
Autoimmune Diseases
Other Applications
6.4. Global Enzyme Immunoassay Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Blood Banks
Clinical Laboratories
Pharmaceutical And Biotech Companies
Academic Research Centers
Other End-Uses
6.5. Global Enzyme Immunoassay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibodies
Antigens
Substrates
Buffers And Stabilizers
6.6. Global Enzyme Immunoassay Market, Sub-Segmentation Of Analyzers Or Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fully Automated EIA Analyzers
Semi-Automated EIA Systems
Microplate Readers
Washers And Incubators
6.7. Global Enzyme Immunoassay Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analysis And Interpretation Software
Laboratory Information System Integration Tools
Instrument Calibration And Validation Services
Technical Support And User Training
7. Enzyme Immunoassay Market Regional And Country Analysis
7.1. Global Enzyme Immunoassay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Enzyme Immunoassay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
